Fostamatinib in chronic immune thrombocytopenia: No comparison—added benefit not proven 2020-10-06 mediabest Health News Fostamatinib is approved for the treatment of chronic immune thrombocytopenia in adults who are refractory to other treatments (in particular to treatment with corticosteroids). The Read more